J
Jose Trabal
Researcher at University of Texas Health Science Center at San Antonio
Publications - 7
Citations - 3076
Jose Trabal is an academic researcher from University of Texas Health Science Center at San Antonio. The author has contributed to research in topics: Estrogen & Medroxyprogesterone acetate. The author has an hindex of 6, co-authored 7 publications receiving 3024 citations.
Papers
More filters
Journal ArticleDOI
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
Valery T. Miller,John C. LaRosa,Vanessa M. Barnabei,Craig M. Kessler,Ginny Levin,Ann Smith-Roth,Margaret Griffin,Diane B. Stoy,Trudy L. Bush,Howard A. Zacur,David A. Foster,Jean Anderson,Alice McKenzie,Susan C. Miller,Peter D. Wood,Marcia L. Stefanick,Robert Marcus,Allison Akana,W. Leroy Heinrichs,Charlene Kirchner,Katherine A. O'Hanlan,Melissa Ruyle,Mary A. Sheehan,Howard L. Judd,Gail A. Greendale,Richard Bayalos,Kathy Lozano,Kathy Kawakami,Elizabeth Barrett-Connor,Robert Langer,Donna Kritz-Silverstein,Mary Lou Carrion-Petersen,Carmela Cavero,Helmut G. Schrott,Susan R. Johnson,Deborah A. Feddersen,Denise L. Krutzfeldt,Jo Ann Benda,Carl J. Pauerstein,Jose Trabal,Robert S. Schenken,Michael P. Stern,Mercedes Rodriguez-Sifuentes,Carann Easton,H B Wells,Mark A. Espeland,George Howard,Robert Byington,Claudine Legault,Sally A. Shumaker,Patricia E. Hogan,Don Hire,Carol Wasilauskas,Margaret K. James,Kathy Lane,Tim Terrell,Stephanie Reece,June J Pierce,Mary Snow,Susan Anthony,Irma Mebane-Sims,Paula T. Einhorn,Sally Hunsberger,Myron A. Waclawiw,Ken Lippel,Diane L. Lucas,Joel Verter,Sherry Jackson,Joseph Kelaghan,Jeffrey M. Perlman,Pam Wolf,Joan McGowan,Stephen Gordon,Stephen Heyse,Judith E. Fradkin,Sherry Sherman,Lot B. Page,Ann Sorenson,Barbara S. Hulka,Baruch A. Brody,Ronald T. Burkman,Robert P. Heaney,Ronald M. Krauss,Harold Roberts,Janet Wittes,Lawrence Riggs,Richard Moss,John J. Albers,Santica M. Marcovina,S. Edwin Fineberg,Russell P. Tracy,Maria J. Merino,Robert E. Scully,Virginia A. LiVolsi,Gerald Kessler +94 more
TL;DR: Estrogen alone or in combination with a progestin improves lipoproteins and lowers fibrinogen levels without detectable effects on postchallenge insulin or blood pressure and in women with a uterus, CEE with cyclic MP has the most favorable effect on HDL-C and no excess risk of endometrial hyperplasia.
Journal ArticleDOI
Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
Howard L. Judd,Irma Mebane-Sims,Claudine Legault,Carol Wasilauskas,Susan Johnson,Maria J. Merino,Elizabeth Barrett-Connor,Jose Trabal,Valery T. Miller,Vanessa M. Barnabei,Ginny Levin,Trudy L. Bush,David C. Foster,Howard A. Zacur,J. Donald Woodruff,Marcia L. Stefanick,Peter D. Wood,Allison Akana,W. Leroy Heinrichs,Katherine A. O'Hanlan,Richard P. Buyalos,Gail A. Greendale,Kathy Lozano,Mary Lou Carrion-Petersen,Carmella Cavero,Robert Langer,Helmut G. Schrott,Jo Ann Benda,Charles deProsse,Deborah Fedderson,Susan R. Johnson,Carl J. Pauerstein,Mohammad M. Ahmad,Herbert P. Brown,Robert S. Schenken,Mercedes Rodriguez-Sifuentes,Philip T. Valente,Mark A. Espeland,H.Bradley Wells,Kathy Lane,Irma L. Mebane-Sims,Joseph Kelaghan,Joan McGowan,Judith E. Fradkin,Sheryl S. Sherman,Robert E. Scully +45 more
TL;DR: Combining CEE with cyclic or continuous MPA or cyclic MP protected the endometrium from hyperplastic changes associated with estrogen-only therapy.
Journal ArticleDOI
Transvaginal Ultrasonography Compared with Endometrial Biopsy for the Detection of Endometrial Disease
Robert Langer,June J Pierce,Katherine A. O'Hanlan,Susan R. Johnson,Mark A. Espeland,Jose Trabal,Vanessa M. Barnabei,Maria J. Merino,Robert E. Scully +8 more
TL;DR: Transvaginal ultrasonography has a poor positive predictive value but a high negative predictive value for detecting serious endometrial disease in asymptomatic postmenopausal women.
Journal ArticleDOI
Cytologic changes in cervical smears associated with prolonged use of depot-medroxyprogesterone acetate†
TL;DR: The authors have observed atrophic and postpartumlike changes in patients receiving depot‐medroxyprogesterone acetate for prolonged periods, which may lead to diagnostic uncertainty or falsely suggest the presence of SIL.
Journal ArticleDOI
Postmenopausal hormone use following a 3-year randomized clinical trial.
Elizabeth Barrett-Connor,Mark A. Espeland,Gail A. Greendale,Jose Trabal,Susan R. Johnson,Claudine Legault,Donna Kritz-Silverstein,Paula Einhorn +7 more
TL;DR: The main predictors of post-PEPI hormone use were those associated with use in the general population (education, ethnicity, geographical region, hysterectomy, and prior use/adherence); and older age, less education, and being non-C Caucasian predicted less hormone use.